Question to the Department of Health and Social Care:

To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton (HL777), why no assessment has been made of the impact of delisting from the Cancer Drugs Fund on the availability of cancer drugs in the United Kingdom.

NHS England has advised that the Cancer Drugs Fund (CDF) is reprioritised on a regular basis so that the resources available are used to the best benefit for patients.

As part of this, NHS England has taken the decision not to consider new drugs for inclusion in the national CDF list at this time and has made no decision on when new applications to the Fund will next be considered.

Clinicians will continue to be able to apply for cancer drugs not on the national CDF list through the Individual Cancer Drugs Funding Request procedure.